- Home
- HNW vs DERM Comparison
HNW vs DERM Comparison
Compare HNW & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNW
- DERM
- Stock Information
- Founded
- HNW 2007
- DERM 2014
- Country
- HNW United States
- DERM United States
- Employees
- HNW N/A
- DERM N/A
- Industry
- HNW Finance/Investors Services
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- HNW Finance
- DERM Health Care
- Exchange
- HNW Nasdaq
- DERM Nasdaq
- Market Cap
- HNW 97.6M
- DERM 87.4M
- IPO Year
- HNW N/A
- DERM 2021
- Fundamental
- Price
- HNW $11.94
- DERM $3.74
- Analyst Decision
- HNW
- DERM Strong Buy
- Analyst Count
- HNW 0
- DERM 3
- Target Price
- HNW N/A
- DERM $9.50
- AVG Volume (30 Days)
- HNW 25.7K
- DERM 61.7K
- Earning Date
- HNW 01-01-0001
- DERM 11-12-2024
- Dividend Yield
- HNW 9.21%
- DERM N/A
- EPS Growth
- HNW N/A
- DERM N/A
- EPS
- HNW 1.19
- DERM N/A
- Revenue
- HNW N/A
- DERM $57,771,000.00
- Revenue This Year
- HNW N/A
- DERM N/A
- Revenue Next Year
- HNW N/A
- DERM $36.49
- P/E Ratio
- HNW $9.85
- DERM N/A
- Revenue Growth
- HNW N/A
- DERM N/A
- 52 Week Low
- HNW $9.80
- DERM $2.85
- 52 Week High
- HNW $11.76
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- HNW 43.40
- DERM 32.80
- Support Level
- HNW $11.91
- DERM $3.54
- Resistance Level
- HNW $12.12
- DERM $3.99
- Average True Range (ATR)
- HNW 0.09
- DERM 0.35
- MACD
- HNW 0.01
- DERM 0.00
- Stochastic Oscillator
- HNW 52.63
- DERM 21.28
About HNW Pioneer Diversified High Income Fund Inc.
Pioneer Diversified High Income Trust is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income as well as capital appreciation. The company invests in various sectors such as Health Care Technology, Household Durables, Oil, Gas and Consumable Fuels, Specialty Retail, Banks, Chemicals, Financial Services, and others. It also invests in convertible bonds, common stock, asset-backed securities, and the U.S Treasury.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.